Older Australians are being bitten more often, and no one yet knows why.
Australia's relationship with its venomous serpents has long been a study in managed coexistence — deadly creatures held in check by functioning hospitals and accessible antivenoms. A new analysis spanning nearly two decades of hospitalization records confirms that the overall burden remains stable, yet beneath that stillness, the landscape is quietly shifting: older Australians are being bitten with increasing frequency, remote communities bear a disproportionate toll, and certain regions are seeing cases climb in ways that demand a more targeted public health response.
- A five percent annual rise in snakebite hospitalizations among Australians aged 65 and over signals that an aging population is encountering danger in ways researchers do not yet fully understand.
- People in very remote areas are hospitalized at nearly 15 times the rate of city dwellers, exposing a stark geographic inequality in who bears the physical cost of living alongside venomous wildlife.
- Brown snakes drove nearly half of all confirmed envenoming cases, yet only one in four patients who showed clinical signs of poisoning actually received antivenom — a gap that raises urgent questions about recognition and treatment protocols.
- Tasmania and the Australian Capital Territory stand apart from the national trend of stability, recording consistent annual increases that may reflect real shifts in human-snake encounters or simply a growing population moving into snake habitat.
- Public health planners are being called to move beyond one-size-fits-all messaging, tailoring prevention and clinical preparedness strategies to the older adults, remote communities, and specific regions where risk is visibly rising.
Australia is home to some of the world's most venomous snakes, yet snakebite deaths remain remarkably rare — typically just two to four per year — thanks to accessible antivenoms and functioning public hospitals. A new analysis of nearly two decades of hospitalization data offers a more nuanced portrait of the problem, one in which the headline number is stable but the details tell a story of quiet, meaningful change.
Between 2002 and 2020, Australian hospitals admitted 10,763 people for snakebite injuries, averaging 566 admissions annually at a rate of 2.6 per 100,000 people — a figure that barely moved across the entire study period. Men were hospitalized more than twice as often as women, with the gap widest among adults aged 25 to 44. But the trend that most caught researchers' attention ran in the opposite direction: hospitalizations among people aged 65 and over rose by five percent each year, while cases among children and younger adults actually declined. Why older Australians are increasingly in harm's way — whether through changing habits, shifting snake populations, or something else — remains an open question.
Geography carved the data just as sharply as age. The Northern Territory recorded the highest hospitalization rate, and people in very remote areas were admitted at nearly 15 times the rate of those in major cities. Most bites occurred at or near home, clustered heavily in the summer months of December through February. Brown snakes accounted for nearly half of all confirmed envenoming cases, yet only about one in four patients with clinical signs of poisoning received antivenom — a striking gap that varied considerably by species.
Two jurisdictions broke from the national pattern of stability: Tasmania and the Australian Capital Territory both recorded statistically significant annual increases in snakebite hospitalizations. Whether these reflect genuine rises in encounters or simply population growth moving into snake territory remains unclear. The researchers acknowledge that hospital discharge data captures only those sick enough to be admitted, likely missing milder cases and offering no window into first-aid quality or post-discharge complications. Even so, the findings carry a clear message for public health planners: prevention and clinical preparedness must be shaped around the people and places where risk is visibly, and measurably, growing.
Australia has one of the world's most venomous snake populations, yet snakebite deaths remain rare—a paradox explained by accessible antivenoms and functioning public hospitals. But a new analysis of nearly two decades of hospitalization records reveals a more complicated picture: while the overall burden of snakebite injuries has stayed flat, certain groups are being bitten more often, and certain places are seeing cases climb.
Between 2002 and 2020, Australian hospitals admitted 10,763 people for snakebite injuries. That works out to roughly 566 admissions per year, or about 2.6 cases for every 100,000 people. The rate barely budged across the entire period. But when researchers from the Australian Venomous Injuries Project broke down the numbers by age, sex, geography, and snake species, patterns emerged that suggest the problem is shifting in ways that demand attention.
Men were hospitalized more than twice as often as women—a gap that was widest among young adults aged 25 to 44, who accounted for roughly a third of all male admissions. This age group, along with those aged 45 to 64, made up more than half of all snakebite hospitalizations. What caught researchers' attention, though, was the trend line for older adults. People aged 65 and over showed a five percent annual increase in snakebite hospitalizations over the study period. People aged 45 to 64 increased by one percent per year. Meanwhile, hospitalizations among children and young adults aged zero to 44 actually declined. The researchers note that understanding why older Australians are being bitten more often—whether due to changing behavior, shifting snake populations, or other factors—requires further investigation.
Geography matters enormously. The Northern Territory recorded the highest hospitalization rate at 7.6 cases per 100,000 people. Queensland followed at 4.3 per 100,000. But the most striking disparity appeared when researchers looked at remoteness: people living in very remote areas were hospitalized at a rate of 15 per 100,000—nearly 15 times higher than those in major cities, where the rate was less than one per 100,000. Most snakebites happened at or near people's homes, though women were injured at home more often than men. About a quarter of hospitalizations occurred while people were working. The injuries clustered in summer months, with December through February seeing nearly six times more hospitalizations than the winter low in June through August.
Brown snakes were responsible for nearly half of all cases where venom was actually injected into the victim. Tiger snakes and black snakes accounted for most of the rest. Yet only about one in four patients with confirmed envenoming received antivenom—roughly 1,184 people out of 4,529 who showed clinical signs of poisoning. The rate varied by species: almost half of taipan bite victims received antivenom, as did 44 percent of tiger snake bite victims, but only 3.8 percent of sea snake bite victims did. Most people hospitalized for snakebite went home the same day. Nearly 90 percent had a length of stay of less than 24 hours.
Two states bucked the overall trend of stability. Tasmania and the Australian Capital Territory both showed statistically significant increases in snakebite hospitalizations across the study period, with annual increases ranging from two to six percent. The researchers note that while these increases are real, it remains unclear whether they reflect genuine changes in snake encounter rates or simply shifts in population size and distribution.
The analysis is based on hospital discharge data coded according to international classification standards, which means it captures people sick enough to need admission but may miss milder cases treated in emergency departments and sent home, or cases managed in the community. The data also cannot reveal whether people received proper first aid—like pressure immobilization bandaging—before reaching hospital, or what complications they developed after discharge. Despite these limitations, the findings align with smaller, more detailed clinical studies and provide a clear picture of who is at risk and where. For public health planners, the message is clear: while snakebite remains uncommon in Australia thanks to good healthcare access, the rising toll among older adults and in specific regions suggests that prevention strategies need to be tailored to match these emerging patterns.
Citações Notáveis
While the overall burden of snakebite in Australia has remained steady, emerging trends among older adults and in specific regions warrant attention.— Study authors
A Conversa do Hearth Outra perspectiva sobre a história
Why does Australia have such a high proportion of venomous snakes but so few deaths?
The antivenoms work, and they're everywhere. About 750 hospitals across the country stock them. When someone gets bitten and makes it to a hospital—which most do, because the population is concentrated in cities—they can get treated quickly. That's the difference between Australia and somewhere like India, where there are 45,000 snakebite deaths a year.
But the study shows hospitalization rates are stable overall. So what's the concern?
The concern is that it's not stable everywhere. Older people are getting bitten more often—five percent more each year for those over 65. And Tasmania and the ACT are seeing increases. We don't know why yet. It could be climate, it could be people spending more time outdoors, it could be snakes moving into new areas.
The data shows most bites happen at home. That's surprising.
It is. About 60 percent of the cases where location was recorded happened at or around the home. Women especially—67 percent of female bites were at home. It suggests this isn't really an occupational hazard for most people. It's just bad luck, being in the wrong place at the wrong time.
Only one in four envenomed patients got antivenom. Why wouldn't everyone get it?
Some bites don't actually inject venom—dry bites. Some people might have been bitten by a non-venomous snake but thought it was venomous. The hospital data can't always distinguish. But also, antivenom isn't risk-free. It can cause allergic reactions. So doctors have to weigh the risk of the venom against the risk of the treatment.
What does the rise in older adults mean?
It could mean they're more vulnerable to serious outcomes if bitten. It could mean they're spending more time in gardens or rural areas. It could mean they're less able to move quickly away from a snake. But honestly, we don't know yet. That's what the researchers are flagging—this is a trend that needs attention and explanation.